hylander: I saw this from another forum, and offer it for

New Post Public Reply Private Reply Replies (3) Message Board
FanMail hylander #28123
346
hylander: I saw this from another forum, and offer it for your consideration. It made sense to me.
If you look at the history of the company, you will see that historically, GNBT made announcements about new products or services, followed a SP bump, and then the company stopped talking about the product/service permanently, and never (and I really mean never, believe it or not) mentioned the product or service again in terms of real revenues generated by the product or service. That was a successful MO for GNBT, until COVID. GNBT tried its usual "quick-pump" approach, expecting (I believe) that no company would be able to develop a deployable vaccine sooner than 4-5 years (the usual time frame), and certainly not within less than a year. That provided cover so GNBT could claim it was working on a vaccine just like everyone else, and announce agreements and memoranda of understanding with other countries and companies, pump the SP, and never have to produce anything. The plan was that COVID would fade into the background like everything before it, and no one would be the wiser. Now, the management is caught with their proverbial pants around their ankles, because other companies ARE coming and HAVE come up with effective vaccines. The only play left to GNBT at this point is to claim they are developing a "better" vaccine (not just one that works, like the "other guys", and they came up with a new scheme - trademark the name "Complete Vaccine." That way, when prospective individual investors do their DD, they see the reference multiple times, associated with GNBT. Of course, it is absolutely meaningless, because it is literally nothing more than two words stuck together and trademarked. How many individual, self-directed investors, though, actually dig down deep to get all the facts, instead of just looking at something that pops up on their screen a few times. That's what has made this truly insidious. Once some people get sucked in, the only way out is to keep praising the company in the hopes that they will be able to get their money back, and get out. Now, because the vaccine scam has not worked, the executives had to come up with something new to distract people away from this glaring failure. The "new" thing? Something they have been mentioning occasionally over the last few months - the listing of NuGenerex. But it's not NGIO, and it's not on the NASDAQ. This is deliberate. They can gin up talk about this stock simply by allowing it to trade, and denying that they knew anything about it being quoted on OTC Pink; with the true believers out there, they will get some folks to buy, even though the company has no more value than GNBT itself. Want proof? Look at GNBT recently, and ask yourself why its price has held or fallen, when GNBT owns 64% of NuGenerex, and NUGX at one point actually climbed all the way to $5.80/share. Something is not right about this. Also, if some of the shares can be traded, and trading is not stopped by the company, why can't ALL the shares be traded now? Why are only some of the shares available? The most popular explanation? Eventually, all the shares will be listed on NSADAQ, under NGIO. If that is true, and it ultimately makes no difference, then ALL the shares should be trading now, and then they all will be "uplisted" to the NASDAQ. There has to be something else dangling out there, something else that can be used in the hope of driving the price up, so that "the game goes one." Ask yourself what accomplishment took place that justified the bonuses paid to the executives. Keep an eye out for those most offensive posters on the boards, because their remarks never are direct, and usually are just explanations/excuses for why the company has not performed. It's can't ALWAYS be someone else's fault (excuse #1), and it is not ALWAYS a matter of "waiting a little longer" (excuse #2). If the company actually produced something, I would have a different attitude, and would be "singing a different tune," but history is certain, and promises are not. Look at the recent "explanations" about some "jumbo certificate," and ask yourself if that sounds like just another excuse. Now, it's time to delay again (weeks until the conference call), so that another "explanation" can be offered.
1

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Plan A Bets on AI in High-Stakes M&A Arena

Updated Category News Views 1

Digging Deeper with AI in M&A Deals Picture this: you’re at the table with a fat corporate M&A deal, eyes darting as you decipher numbers and nods, when out swings Plan A Technologies with their new ace up their sleeve—a stealth AI assessment tool armed to sharpen their technical due diligence. Unmasking the Tech Jigsaw Las Vegas-based Plan A Technologies hasn't just...

Continue Reading
Acer's New Monitors: ePaper, Triple Displays & More

Updated Category News Views 8

Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....

Continue Reading
UNISORB Expands Reach with BILZ Acquisition

Updated Category News Views 0

UNISORB Acquisition: A Game-Changer for Industrial Solutions This ain't the first time a company took over another to expand its footprint, but UNISORB's latest move to scoop up BILZ-USA is worth a closer look. Everybody's talking about this takeover that throws UNISORB right into the spotlight of North America's industrial sector. Naming them the exclusive distributor of...

Continue Reading
Tradr's Bold Venture: Anthropic ETFs Ahead of IPO

Updated Category News Views 2

Why Tradr Is Diving Into Anthropic's Hype There's a whiff of anticipation in the air as Anthropic gears up for its much-anticipated IPO, and Tradr isn't sitting on its hands here. They've just filed for two ETFs—one long, one short—ahead of the big day. We're talking about ANTT and ANTZ, betting on leveraged and inverse plays on whatever whirlwind Anthropic's stock...

Continue Reading
York Urged to Retire Research Macaques After Probe

Updated Category News Views 4

Undercover Investigation Shakes Up York University If you thought the world of research was all about sterile labs and the pursuit of knowledge, think again. The Jane Goodall Institute (JGI), famed for championing animal welfare, has urged York University to let go of nine long-suffering rhesus macaques. Turns out, these macaques weren't exactly living their best lives....

Continue Reading
Early Education's Massive Impact: Key Skills for Success

Updated Category News Views 2

Unlocking Lifelong Success: The Early Advantage Ever look at a successful adult and wonder, "Where'd they get that spark?" According to HelloNation and child care expert Karen Ego, it all starts early. Think of early learning not just as prepping for school, but as the first blueprint for life's journey. It's the skills you pick up in those tender years that stick it out...

Continue Reading
Backroads Sets 2027 Egypt Tour with Active Adventures

Updated Category News Views 1

Backroads Brings Adventure Travel to Egypt in 2027 There's an entirely fresh way to get your kicks by the pyramids, and it's coming straight from Backroads, the bigwig of active travel. They're rolling out a Multi-Adventure Tour in the heart of Egypt for 2027. It's got all the bells and whistles: hiking, biking, and kayaking, packaged with a side of luxury at posh hotels...

Continue Reading
Texas Institute Leads Trailblazing Arrhythmia Study

Updated Category News Views 2

Breaking New Ground in Heart Rhythm Treatment Well, here's a twist that even the stock market folks might envy—pioneering innovation in healthcare. This time, it’s not about tech stocks or a bull market, but about real human lives. The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin has jumped to the forefront by participating in a...

Continue Reading
Evotec and Plectonic Join Forces on Tumor Immunotherapy

Updated Category News Views 4

Collaboration Spotlight: A New Horizon for Tumor Treatments Ever wonder why curing solid tumors has been such a tough nut to crack? Evotec SE (NASDAQ: EVO) and Plectonic Biotech are wagering that their collaboration might just hold the key to unlocking new answers. They’re pooling their cutting-edge tech to take a fresh swing at this stubborn problem. Here’s what’s...

Continue Reading
Codoxo Snags 2026 Award for AI Payment Innovation

Updated Category News Views 1

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Continue Reading

Top 5 Most Recently Viewed Articles

EUROAPI's Strategic Sale of Haverhill Site to Particle Dynamics

Updated Category News Views 209

EUROAPI Strategically Divests Haverhill Site EUROAPI has undertaken a significant step in optimizing its industrial footprint by announcing the sale of its Haverhill manufacturing site to Particle Dynamics, a prominent name in particle processing and delivery technologies. This transaction reinforces EUROAPI's commitment to its FOCUS-27 transformation plan aimed at...

Continue Reading
Safe and Green Development Corporation Achieves Financial Milestone

Updated Category News Views 150

Safe and Green Development Corporation Achieves Financial Stability Miami — Safe and Green Development Corporation (NASDAQ: SGD), a prominent player in the real estate and technology development sector, recently made headlines with an important announcement: the complete satisfaction and retirement of all outstanding convertible debt obligations. This is more than just...

Continue Reading
Ethan Allen Prepares for Fiscal 2025 Second Quarter Earnings

Updated Category News Views 174

Ethan Allen's Upcoming Earnings Release Ethan Allen Interiors Inc. is gearing up for the release of its financial results for the fiscal 2025 second quarter, which concluded on December 31, 2024. This announcement reflects the company’s commitment to transparency and engagement with its stakeholders. The release is anticipated to occur after market hours on a Wednesday,...

Continue Reading
MY DR NOW Expands Convenient Family Care in Chandler Area

Updated Category News Views 103

MY DR NOW Opens New Family Clinic to Serve Busy Families MY DR NOW, known for its dedication to family health, has recently opened a family medicine clinic designed with the busy lifestyles of modern families in mind. This new clinic in Chandler is a game-changer for families trying to fit healthcare into their hectic schedules. Strategic Location for Easy Access...

Continue Reading
Nykredit Realkredit A/S Updates on Prepayments Insights

Updated Category News Views 150

Understanding Nykredit Realkredit A/S Prepayment Updates Nykredit Realkredit A/S is dedicated to keeping its investors informed on key financial metrics. Today, we explore the latest updates on prepayments data, specifically pertaining to CK93. Key Highlights from the Prepayment Data The latest prepayment data for CK93, as mandated by the Danish Capital Markets Act,...

Continue Reading